-
重大传染病包括新发传染病和病毒性肝炎、艾滋病、结核病等重要的传染病,不仅危害人类健康,而且严重影响全球经济发展、社会稳定以及国家安全。近几十年来,病原体出现跨物种、跨地域传播、耐药性增强等问题,造成新发、突发传染病不断出现,成为地区性或国际性公共卫生问题,给传染病防治带来新的挑战。本文回顾了新中国传染病的防治历程和主要成就,并概要介绍了重大传染病的治疗进展和发展方向。
中国重大传染病的防治进展及治疗挑战
-
-
[1] 张大庆. 历史上重大传染病的始与终[J]. 中国医学人文, 2020, 6(2): 68. [2] 涂鸣华, 季赟鋆. 新中国成立以来应对重大传染病疫情对外传播史研究[J]. 对外传播, 2020(7): 46. [3] 王文. 传染病与大国兴衰——基于历史实例的研究[J]. 政治学研究, 2021(2): 136. [4] 王凝芳, 朱纯吾, 张树林, 等. 首例中国大陆居民艾滋病[J]. 中华医学杂志, 1991(12): 671. [5] 黄磊, 李中杰, 王福生, 等. 新中国成立70年来在传染病防治领域取得的成就与展望[J]. 中华全科医学, 2019, 17(10): 1615. [6] 刘文宣, 刘殿武. 我国重大传染病防控成就举世瞩目[J]. 疑难病杂志, 2021, 20(11): 1081. [7] HUANG F, GUO J, ZOU Z, et al. Angiotensin Ⅱ plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients[J]. Nat Commun, 2014, 5: 3595. [8] XU Z, SHI L, WANG Y, et al. Pathological findings of SARS-COV-2 associated with acute respiratory distress syndrome[J]. Lancet Respir Med, 2020, 8(4): 420. [9] 王华晨, 胡建功. Peg-IFNα/NA联合治疗慢乙肝的进展[J]. 泰山医学院学报, 2019, 40(11): 873. [10] WANG D, FU B, SHEN X, et al. Restoration of HBV-specific CD8(+) T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-alpha therapy[J]. Signal Transduct Target Ther, 2021, 6(1): 376. [11] BREZAR V, HANI L, SURENAUD M, et al. Negative modulation of suppressive HIV-specific regulatory T cells by IL-2 adjuvanted therapeutic vaccine[J]. PLoS Pathog, 2017, 13(7): e1006489. [12] CHIU CY, CHANG JJ, DANTANARAYANA AI, et al. Combination immune checkpoint blockade enhances IL-2 and CD107a production from HIV-specific T Cells ex vivo in people living with hiv on antiretroviral therapy[J]. J Immunol, 2022, 208(1): 54. [13] BENGSCH B, MARTIN B, THIMME R. Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation[J]. J Hepatol, 2014, 61(6): 1212. [14] LI TT, WANG ZR, YAO WQ, et al. Stem cell therapies for chronic liver diseases: progress and challenges[J]. Stem Cells Transl Med, 2022, 11(9): 900. [15] SHI L, HUANG H, LU X, et al. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe SARS-COV-2 patients: a randomized, double-blind, placebo-controlled phase 2 trial[J]. Signal Transduct Target Ther, 2021, 6(1): 58. [16] XU R, ZHANG JY, TU B, et al. HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients[J]. Signal Transduct Target Ther, 2021, 6(1): 174.
点击查看大图
计量
- 文章访问数: 3128
- HTML全文浏览量: 1008
- PDF下载量: 45
- 被引次数: 0